SKBI

From China Stock Market

From Reuters: Skystar Bio-Pharmaceutical Company is a holding company that, through its variable interest entity (VIE), Xian Tianxing Bio-Pharmaceutical Co., Ltd. (Xian Tianxing), develops, manufactures and distributes medicines, vaccines and other healthcare and medical care products for poultry, livestock and domestic pets in the People’s Republic of China. The Company has four product lines, including a vaccine line, a veterinary medicine line, a fodder and feed additives line, and a micro-organism line. All four product lines are developed, manufactured and distributed by Xian Tianxing, which the Company operates and controls through contractual arrangements between its indirect wholly owned subsidiary, Sida Biotechnology (Xian) Co., Ltd. (Sida) and Xian Tianxing. Skystar's business divisions include a bio-pharmaceutical products division, a veterinary drugs division, a fodder and feed additive division, and a microorganism preparation division.